Recombinant immunotoxins--the next generation.
Barth
Stefan
S
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D055808:Drug Discovery / Q000379:methods; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D000922:Immunotoxins; D011994:Recombinant Proteins